|
MARCH7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.181900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.663200E-03 |
| Normal-vs-Stage2 |
2.047700E-04 |
| Normal-vs-Stage3 |
1.960050E-04 |
| Normal-vs-Stage4 |
3.35829999997816E-06 |
| Stage1-vs-Stage2 |
3.810400E-02 |
| Stage1-vs-Stage3 |
1.172040E-01 |
| Stage1-vs-Stage4 |
4.897100E-03 |
| Stage2-vs-Stage3 |
3.852800E-01 |
| Stage2-vs-Stage4 |
8.473000E-01 |
| Stage3-vs-Stage4 |
2.277800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.587780E-04 |
| Normal-vs-AfricanAmerican |
2.463600E-01 |
| Normal-vs-Asian |
1.608490E-02 |
| Caucasian-vs-AfricanAmerican |
1.676400E-01 |
| Caucasian-vs-Asian |
5.099600E-01 |
| AfricanAmerican-vs-Asian |
4.315000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.390600E-04 |
| Normal-vs-Female |
3.772500E-04 |
| Male-vs-Female |
9.825800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.821930E-02 |
| Normal-vs-Age(41-60Yrs) |
1.825200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.90095000000001E-05 |
| Normal-vs-Age(81-100Yrs) |
8.057700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.993600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.196800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.464400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.808800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.470000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.784400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.461600E-02 |
| Classical-VS-Follicular |
1.446390E-02 |
| Classical-VS-Other |
3.134400E-01 |
| Classical-VS-Normal |
6.202400E-03 |
| Tall-VS-Follicular |
9.621800E-01 |
| Tall-VS-Other |
9.887600E-01 |
| Tall-VS-Normal |
8.162500E-04 |
| Follicular-VS-Other |
9.705000E-01 |
| Follicular-VS-Normal |
2.034500E-04 |
| Other-VS-Normal |
4.687600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.3590999999934E-05 |
| Normal-vs-N1 |
8.753600E-04 |
| N0-vs-N1 |
7.169800E-01 |
|
|
